NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
1-Year Return 12.08%
This Quarter Return
+21.6%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.55B
AUM Growth
+$969M
Cap. Flow
+$810M
Cap. Flow %
52.17%
Top 10 Hldgs %
88.53%
Holding
32
New
3
Increased
3
Reduced
1
Closed
3

Sector Composition

1 Healthcare 37.72%
2 Communication Services 6.13%
3 Technology 5.06%
4 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$539B
$708M 45.58%
+4,325,200
New +$708M
INGN icon
2
Inogen
INGN
$233M
$243M 15.62%
3,549,321
CABO icon
3
Cable One
CABO
$946M
$95.2M 6.13%
63,947
+18,947
+42% +$28.2M
AAPL icon
4
Apple
AAPL
$3.52T
$78.6M 5.06%
1,071,152
MIRM icon
5
Mirum Pharmaceuticals
MIRM
$3.72B
$60M 3.86%
2,445,147
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$45.4M 2.92%
2,645,446
GRTX
7
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$44.9M 2.89%
+3,409,021
New +$44.9M
MIST icon
8
Milestone Pharmaceuticals
MIST
$168M
$39M 2.51%
2,434,470
-240,000
-9% -$3.84M
BN icon
9
Brookfield
BN
$103B
$38.9M 2.5%
+1,256,843
New +$38.9M
FOLD icon
10
Amicus Therapeutics
FOLD
$2.4B
$22.6M 1.45%
2,317,870
AKBA icon
11
Akebia Therapeutics
AKBA
$774M
$19.6M 1.26%
3,100,000
SIBN icon
12
SI-BONE Inc
SIBN
$666M
$19.2M 1.24%
892,684
AERI
13
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$16.2M 1.04%
670,036
CRVS icon
14
Corvus Pharmaceuticals
CRVS
$431M
$15.9M 1.03%
2,927,560
SPNE
15
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$15.7M 1.01%
1,308,037
BPMC
16
DELISTED
Blueprint Medicines
BPMC
$13.7M 0.88%
170,667
INSP icon
17
Inspire Medical Systems
INSP
$2.39B
$13M 0.84%
175,000
ETTX
18
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$10.8M 0.7%
2,181,843
SILK
19
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$9.89M 0.64%
245,000
SPRO icon
20
Spero Therapeutics
SPRO
$106M
$8.95M 0.58%
931,099
+465,116
+100% +$4.47M
XENT
21
DELISTED
Intersect ENT, Inc
XENT
$5.42M 0.35%
217,709
VRNA
22
Verona Pharma
VRNA
$9.2B
$4.26M 0.27%
740,740
CRNX icon
23
Crinetics Pharmaceuticals
CRNX
$3.19B
$3.39M 0.22%
135,009
PTGX icon
24
Protagonist Therapeutics
PTGX
$3.63B
$3.38M 0.22%
479,074
STIM icon
25
Neuronetics
STIM
$197M
$3.31M 0.21%
736,578
+108,230
+17% +$486K